Abstract
We optimized the assay for detection of cytokeratin 19 (CK19) mRNA by the reverse transcriptase-polymerase chain reaction (RT-PCR) in blood as an index of circulating tumor cells in breast cancer patients. The limit of detection of <1 MCF7 tumor cells per 106 peripheral blood leukocytes (PBL) was achieved in mixing experiments. We did not detect CKl9 mRNA in control bloods (0/30) or in the blood of patients with benign breast disease (0/15). In blood samples from 109 patients with invasive breast cancer, CK19 mRNA was detected in 7/23 patients with node-negative disease, in 21/58 with node-positive disease, and in 20/28 with distant metastases. There was a significant association (P<0.01) of CK19 positivity with distant metastatic versus both node-negative and node-positive disease, but not with any other histopathological parameter examined. In a small number of patients with distant metastases, increased intensity of the CK19 RT-PCR signal was associated with a reduced survival.
Similar content being viewed by others
References
Stasiak PC, Purkis PE, Leigh IM, Lane EB: Keratin 19: Predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 92: 707–716, 1989
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475–482, 1994
Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2886–2990, 1994
Peck K, Sher Y-P, Shih J-Y, Roffler SR, Wu C-W, Yang P-C: Detection and quantitation of circulating cancer cells in peripheral blood of lung cancer patients. Cancer Res 58: 2761–2765, 1998
Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S: Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 72: 408–411, 1997
Yeh K-H, Chen Y-C, Yeh S-H, Chen C-P, Lin J-T, Cheng A-L: Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res 18: 1283–1286, 1998
Dingemans A-MC, Brakenhoff RH, Postmus PE, Giaccone G: Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest 77: 213–220, 1997
Page DL, Jensen RA, Simpson JF: Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat 51: 195–208, 1998
Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R: Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 80: 569–578, 1999
Chomczynski P, Sacchi N: A single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chioroform extraction. Anal Biochem 162: 156–159, 1987
Grandchamp B, De Verneuil H, Beaumont C, Chretien S, Walter O, Nordmann Y: Tissue-specific expression of porphobilinogen deaminase, two isoenzymes from a single gene. Eur J Biochem 162: 105–110, 1987
Chretien S, Dubart A, Beaupain D, Raich N, Grandchamp B, Rosa J, Gossens M, Romeo P-H: Alternative transcription and splicing of the human porphobilinogen deaminase gene resulting either in tissue-specific or in housekeeping gene expression. Proc Natl Acad Sci USA 85: 6–10, 1988
Savtchenko ES, Schiff TA, Jiang C-K, Freedberg IM, Blumenberg M: Embryonic expression of human 40-kD keratin: evidence from a processed pseudogene sequence. Am J Hum Genet 43: 630–637, 1988
Mansi JL, Easton D, Berger U, Gazet J-C, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years follow-up. Eur J Cancer 27: 1552–1555, 1991
Cote RJ, Rose PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micromestastases. J Clin Oncol 9: 1749–1756, 1991
Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: long-term follow-up of the first patient cohort. Eur J Cancer 27: 236–239, 1991
Ménard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. Br J Cancer 69: 1126–1129, 1994
Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14: 1868–1876, 1996
Krüger W, Krzizanowski C, Holweg M, Stockschläder M, Kröger N, Jung R, Mross K, Jonat W, Zander AR: Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122: 679–689, 1996
Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet J-C, Sacks N, Bender HG, Luqmani Y, Coombes RC: The detection of micromestastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854–861, 1997
Slade MJ, Smith BM, Sinnett HD, Cross NCP, Coombes RC: Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17: 870–879, 1999
Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DSB: Limitations of specific reverse transcriptase-polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632–2640, 1998
Brossart P, Schmier J-W, Krüger S, Willhauck M, Scheibenbogen C, Möhler T, Keilholz U: A polymerase chain reactionbased semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 55: 4065–4068, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kahn, H.J., Yang, LY., Blondal, J. et al. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters. Breast Cancer Res Treat 60, 143–151 (2000). https://doi.org/10.1023/A:1006350913243
Issue Date:
DOI: https://doi.org/10.1023/A:1006350913243